Kentucky Appeals Court Backs Infuse Off-Label Preemption, But Not For Hospital
Mealey's (February 1, 2017, 11:40 AM EST) -- FRANKFORT, Ky. — A Kentucky Court of Appeals panel on Jan. 13 affirmed that a patient’s product liability claim over the off-label use of Infuse bone graft is preempted by federal...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login